Log In
Print this Print this

PF-05190457, PF-5190457

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionGhrelin receptor (GHSR) antagonist
Molecular Target Ghrelin receptor (GHSR)
Mechanism of ActionGhrelin receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today